Search hospitals > North Carolina > Salisbury
Rowan Regional Medical Center
Claim this profileSalisbury, North Carolina 28144
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
18 reported clinical trials
5 medical researchers
Summary
Rowan Regional Medical Center is a medical facility located in Salisbury, North Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Rowan Regional Medical Center is involved with conducting 18 clinical trials across 73 conditions. There are 5 research doctors associated with this hospital, such as Alan Skarbnik, MD, Nasfat Shehadeh, M.D., Kimberly S. Strickland, and Kevin S. Roof.Area of expertise
1Breast Cancer
HER2 negative
ER positive
PR positive
2Lung Cancer
Stage II
Stage I
ALK positive
Top PIs
Alan Skarbnik, MDNovant Health Presbyterian Medical Center5 years of reported clinical research
Studies Lymphoma
Studies Chronic B-Cell Leukemia
7 reported clinical trials
15 drugs studied
Nasfat Shehadeh, M.D.Novant Health Presbyterian Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Carcinoma
5 reported clinical trials
11 drugs studied
Kimberly S. StricklandNovant Health Presbyterian Medical Center1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
5 reported clinical trials
17 drugs studied
Kevin S. RoofNovant Health Presbyterian Medical Center5 years of reported clinical research
Studies Lung Cancer
Studies Oral Squamous Cell Carcinoma
3 reported clinical trials
12 drugs studied
Clinical Trials running at Rowan Regional Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Ovarian Tumors
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Choriocarcinoma
Germ Cell Tumors
Testicular Choriocarcinoma
Testicular Tumor
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rowan Regional Medical Center?
Rowan Regional Medical Center is a medical facility located in Salisbury, North Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Rowan Regional Medical Center is involved with conducting 18 clinical trials across 73 conditions. There are 5 research doctors associated with this hospital, such as Alan Skarbnik, MD, Nasfat Shehadeh, M.D., Kimberly S. Strickland, and Kevin S. Roof.